Pharmacovigilance in the Clinical Department
Drug safety is complex and cannot be reduced to individual measures. Continuous quality assurance requires the coordination of a series of processes involving specialist expertise in line with the current state of research.
There is close interdisciplinary cooperation with Clinical Departments from the MHH in the diagnosis and treatment of patients.